Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
Earnings Data
Report Date
Aug 11, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.18Last Year’s EPS
-0.22Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 05, 2025
|% Change Since: 28.63%
|Next Earnings Date:Aug 11, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, increased physician engagement, and improved gross margins, but also acknowledged challenges such as ongoing net losses, slow international revenue growth, and pending regulatory decisions. The overall sentiment is cautiously optimistic with strong operational performance but mindful of external conditions.Company Guidance
In the recent earnings call, SI-BONE provided a comprehensive update on its financial performance and future outlook. The company reported a robust worldwide revenue of $47.3 million for the first quarter of 2025, marking a 24.9% increase, with U.S. revenue growing by 26.6%. The company achieved an impressive gross margin of 79.7%, up by nearly 80 basis points, and reported positive adjusted EBITDA of $0.5 million. SI-BONE's active physician base expanded by 27%, and procedure volume grew by 27.3% in the U.S. The company also updated its full-year revenue guidance to a range of $193.5 million to $197.5 million, reflecting anticipated year-over-year growth of 16% to 18%. The guidance also suggests an improvement in full-year gross margin expectations to 78%. With positive adjusted EBITDA already achieved and plans for further territory expansion, SI-BONE remains optimistic about its ability to reach free cash flow by 2026.Strong Revenue Growth
Worldwide revenue for the quarter reached $47.3 million, representing approximately 25% growth. U.S. revenue was $44.8 million, reflecting approximately 27% growth.
Positive Adjusted EBITDA
The company delivered positive adjusted EBITDA of approximately $0.5 million compared to an adjusted EBITDA loss of $4 million in the first quarter of 2024.
Significant Increase in Physician Engagement
Over 1,400 US physicians performed procedures using SI-BONE's products, marking a 27% increase in the physician base.
New Product Launch and Development
SI-BONE plans to launch a new SI joint fusion solution in Q1 2026 and is developing a third breakthrough device targeting a pressing need in spine surgery.
Improved Gross Margins
Gross margin rate for the quarter was 79.7%, an improvement of nearly 80 basis points.
Increased Product Adoption
Notable adoption of the iFuse Bedrock Granite 9.5, with a 69% growth in four implant Granite cases compared to the prior year.
---
SIBN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SIBN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| May 05, 2025 | $14.25 | $16.45 | +15.44% |
| Feb 24, 2025 | $17.47 | $18.44 | +5.55% |
| Nov 12, 2024 | $15.63 | $13.14 | -15.93% |
| Aug 05, 2024 | $14.04 | $14.22 | +1.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does SI-Bone Inc (SIBN) report earnings?
SI-Bone Inc (SIBN) is schdueled to report earning on Aug 11, 2025, TBA Not Confirmed.
What is SI-Bone Inc (SIBN) earnings time?
SI-Bone Inc (SIBN) earnings time is at Aug 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SIBN EPS forecast?
SIBN EPS forecast for the fiscal quarter 2025 (Q2) is -0.18.
---